J Ultrasound. 2022 Sep;25(3):649-654. doi: 10.1007/s40477-021-00639-y. Epub 2022 Jan 8.
PMID:34997562
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma.
Rini BI, Albiges L, Tang X, Koeppen H, Bex A, Suárez C, Uzzo R, Hamidi H, Assaf ZJ, Dubey S, Goluboff ET, Carter C, Pal SK, Banchereau RF, Xu W, Huseni MA.
Ann Oncol. 2025 Dec;36(12):1525-1534. doi: 10.1016/j.annonc.2025.08.007. Epub 2025 Aug 28.
PMID:40885527
Bilateral xanthogranulomatous pyelonephritis.
Tsai KH, Lai MY, Shen SH, Yang AH, Su NW, Ng YY.
J Chin Med Assoc. 2008 Jun;71(6):310-4. doi: 10.1016/S1726-4901(08)70128-X.
PMID:18567562
Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma.
Cho CW, Lee KW, Park H, Kim HJ, Park JB, Choi YL, Yu JI, Lee SJ, Choi DI, Kim SJ.
Asia Pac J Clin Oncol. 2018 Oct;14(5):e465-e471. doi: 10.1111/ajco.12769. Epub 2017 Oct 18.
PMID:29044883
Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N, Wilhelm A, Döbert N, Menzel C, Gossmann J, Berner U, Zaplatnikov K, Scheuermann EH, Grünwald F.
Nuklearmedizin. 2005;44(5):200-4.
PMID:16395496
Native nephrectomy in polycystic kidney disease patients on transplant lists: how and when?
Copur S, Ozbek L, Guldan M, Topcu AU, Kanbay M.
J Nephrol. 2024 Jul;37(6):1463-1475. doi: 10.1007/s40620-024-01899-7. Epub 2024 Mar 21.
PMID:38512371
Residual renal volume as a long-term independent predictive factor of developing chronic kidney disease after donor nephrectomy.
Hoontrakul T, Leenanupunth C, Siantong M, Sirisreetreerux P, Phongkitkarun S, Kongchareonsombat W, Kijvikai K.
Sci Rep. 2024 Mar 4;14(1):5341. doi: 10.1038/s41598-024-55499-3.
PMID:38438514
[A Case in Which a Distal Pancreatectomy Was Performed for Pancreatic Metastasis of Renal Cell Carcinoma after Nephrectomy, and a Total Pancreatectomy Was Performed for Residual Pancreatic Recurrence].